This page is part of the FHIR Specification (v4.6.0: R5 Draft Ballot). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Device, Encounter, Patient, Practitioner, RelatedPerson |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicationAdministration.
Generated Narrative
status: completed
- |
* |
occurence: 15 Jan. 2015, 2:30:00 pm --> 16 Jan. 2015, 12:30:00 am
- |
* |
request: Generated Summary: id: 12345689 (OFFICIAL); status: completed; intent: order; authoredOn: 2015-01-15
- | Text | Route | Method | Dose |
* | Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk | Intravenous route (qualifier value) | Inject - dosing instruction imperative (qualifier value) | 3 mg |
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.